Recombinant multi-species DGKD protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine DGKD protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a cytoplasmic enzyme that phosphorylates diacylglycerol to produce phosphatidic acid. Diacylglycerol and phosphatidic acid are two lipids that act as second messengers in signaling cascades. Their cellular concentrations are regulated by the encoded protein, and so it is thought to play an important role in cellular signal transduction. Alternative splicing results in two transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]
The Alternative Names of target: 130 kDa diacylglycerol kinase,D330025K09,DAG kinase delta,DGK-delta,DGKD,DGKdelta,Dgkd,Diacylglycerol kinase delta,Diglyceride kinase delta (DGK-delta),RGD1563309,dgkd-2
Go
to DGKD products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP13123-Ag-1/ GM-Tg-hg-IP13123-Ag-2 | Human DGKD protein | Human |
| GM-Tg-rg-IP13123-Ag-1/ GM-Tg-rg-IP13123-Ag-2 | Rat DGKD protein | Rat |
| GM-Tg-mg-IP13123-Ag-1/ GM-Tg-mg-IP13123-Ag-2 | Mouse DGKD protein | Mouse |
| GM-Tg-cynog-IP13123-Ag-1/ GM-Tg-cynog-IP13123-Ag-2 | Cynomolgus/Rhesus macaque DGKD protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP13123-Ag-1/ GM-Tg-felg-IP13123-Ag-2 | Feline DGKD protein | Feline |
| GM-Tg-cang-IP13123-Ag-1/ GM-Tg-cang-IP13123-Ag-2 | Canine DGKD protein | Canine |
| GM-Tg-bovg-IP13123-Ag-1/ GM-Tg-bovg-IP13123-Ag-2 | Bovine DGKD protein | Bovine |
| GM-Tg-equg-IP13123-Ag-1/ GM-Tg-equg-IP13123-Ag-2 | Equine DGKD protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP13123-Ag-1/ GM-Tg-hg-IP13123-Ag-2;
GM-Tg-rg-IP13123-Ag-1/ GM-Tg-rg-IP13123-Ag-2;
GM-Tg-mg-IP13123-Ag-1/ GM-Tg-mg-IP13123-Ag-2; GM-Tg-cynog-IP13123-Ag-1/ GM-Tg-cynog-IP13123-Ag-2; GM-Tg-felg-IP13123-Ag-1/ GM-Tg-felg-IP13123-Ag-2; GM-Tg-cang-IP13123-Ag-1/ GM-Tg-cang-IP13123-Ag-2; GM-Tg-bovg-IP13123-Ag-1/ GM-Tg-bovg-IP13123-Ag-2; GM-Tg-equg-IP13123-Ag-1/ GM-Tg-equg-IP13123-Ag-2 |
| Products Name | DGKD protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | DGKD |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine DGKD protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.